Global University Venturing

ChromaCure has spun out of Université libre de Bruxelles with $19.6m in funding to commercialise treatments for cancer based on a new understanding on tumour metastasis.

The newly-launched UCLA spinout is targeting rare and treatment-resistant forms of epilepsy with an approach drawing on certain kinds of gut bacteria.

The fund will back dozens of project teams each year, while giving some students and graduates a spot on its investment committee.

Beetlebox has been launched by Imperial Innovations to commercialise research conducted by Andrew Swirski.

The hub will operate a venture capital fund, an accelerator and a facilitator of university-industry collaboration.

Epic Conjoint, This is Seaweed and Travacoin have spun into NovaUCD, the innovation hub at University College Dublin, with a view of raising $8.7m within two years.

A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.

The Oxford spinout has lured funding from OSI and the university itself as it aims to meet performance milestones for its peptide drug discovery programs.

UCLA's Magnify is looking for more local startups to join the 21 companies it currently supports, 80% of which operate in the life science sector.

Tel Aviv University’s TTO has set up a business called Nemis Technologies in partnership with BioSynth to develop pathological bacteria detection technologies powered by chemiluminescence.

Optical network technology RoadMap spun out from Cambridge in 2014 and had raised more than $2.3m before the series B round.